Share Tips: This week’s buy, hold and sell recommendations
Every week two experts from our Share Tips columnist pool give us their buy, hold and sell recommendations.
Stockhead
Barry FitzGerald: Hammer returns to take a swing at one of WA’s hottest gold prospects
Hammer Metals has a handy bounty of QLD copper and molybdenum, but this famous WA gold ground has ‘Garimpeiro’ Barry FitzGerald intrigued.
Recce secures Chinese patent for superbug drugs
Recce Pharmaceuticals secures patent acceptance in China for synthetic anti-infectives as it targets growing global health problem of antibiotic-resistant superbugs.
NNL advances Finnish gold projects
Armed with A$6 million in cash, Nordic Resources will focus on unlocking value from three Finnish gold assets acquired from Northgold.
More Stories
Which metals won in April?
Gold and uranium rose in April but the impact of the US-China trade war loomed large over commodity markets.
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
Dimerix banks US$30m in US licensing deal
Dimerix has received a US$30m (~$48m) upfront payment from Amicus Therapeutics under a US licensing deal for its phase III candidate in rare kidney disease.
StockTake: Trek Metals
Trek Metals continues to make exploration strides at its Christmas Creek project in Western Australia.
A new mineral sands hotspot in Sri Lanka
With major regulatory hurdles cleared, production is within reach at Titanium Sands’ Mannar Island project.
ATC advances silicon in batteries tech
Altech’s latest Silumina Anode technological breakthrough has delivered a 50% capacity improvement in battery applications.
BTR US$11.5m working capital facility to advance gold production
Brightstar Resources has executed a working capital facility with Ocean Partners Australia to boost CY25 production and accelerate exploration.
NTI164 shows strong safety in tox tests
Neurotech clears key safety hurdle for NTI164, paving the way for longer studies and global filings.
EBR applies for cardiac device outpatient reimbursement
Having already received a recommendation for inpatients from the CMS, EBR is now applying for reimbursement for its WISE CRT System for outpatients under the same criteria.
KNG starts Leliyn scoping study
Kingsland’s scoping study for Leliyn will be underpinned by the initial indicated resource of 1Mt contained graphite.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/55